Carlotta Palumbo
University of Brescia
Robotic surgeryQuality of lifeEpidemiologyCancerInternal medicineRadiologyUrologySurgeryOncologyRenal functionRetrospective cohort studyRandomized controlled trialStage (cooking)Prospective cohort studyObservational studySexual functionCystectomyRenal cell carcinomaProstatectomyProstate cancerNephrectomyProgression-free survivalPopulationPositive Surgical MarginIn patientCancer specific mortalityPerioperativeMultivariate analysisRadiation therapyMedicineCohort
51Publications
9H-index
205Citations
Publications 50
Newest
BACKGROUND This study analyzes patient health-related quality of life (QoL) 24-month after prostate cancer (PCa) diagnosis within the PROState cancer monitoring in ITaly from the National Research Council (Pros-IT CNR) study. METHODS Pros-IT CNR is an ongoing, longitudinal and observational study, considering a convenience sample of patients enrolled at PCa diagnosis and followed at 6, 12, 24, 36, 48 and 60 months from the diagnosis. Patients were grouped according to the treatment received: ner...
1 CitationsSource
#1Ahmet Bindayi (UCSD: University of California, San Diego)H-Index: 8
#2Riccardo Autorino (VCU: Virginia Commonwealth University)H-Index: 68
Last. Ithaar H. Derweesh (UCSD: University of California, San Diego)H-Index: 43
view all 37 authors...
Abstract Background Partial nephrectomy (PN) in elderly patients is underutilized with concerns regarding risk of complications and potential for poor outcomes. Objective To evaluate quality and functional outcomes of PN in patients >75 yr using trifecta as a composite outcome of surgical quality. Design, setting, and participants Multicenter retrospective analysis of 653 patients aged >75 yr who underwent PN (REnal SURGery in Elderly [RESURGE] Group). Intervention PN. Outcome measurements and s...
8 CitationsSource
#1Salvatore Grisanti (University of Brescia)H-Index: 21
#2Deborah Cosentini (University of Brescia)H-Index: 7
Last. Alfredo Berruti (University of Brescia)H-Index: 2
view all 8 authors...
Source
#1Alessandro Antonelli (University of Brescia)H-Index: 30
#2Carlotta Palumbo (University of Brescia)H-Index: 9
Last. Claudio Simeone (University of Brescia)H-Index: 28
view all 10 authors...
Abstract Background A recent multi-center study showed how estimated glomerular filtration rate (eGFR) and cancer specific mortality (CSM) are linearly and inversely related in organ-confined renal carcinoma (RCC), whenever the eGFR decreases below specific thresholds. We addressed our previous work limitations related to heterogeneity and missing data, and to explore the relationship between eGFR and CSM also in locally advanced RCC. Materials and methods All RCC patients treated with either pa...
1 CitationsSource
#1Alberto Dalla Volta (University of Brescia)H-Index: 7
#2Gherardo Mazziotti (Humanitas University)H-Index: 55
Last. Alfredo Berruti (University of Brescia)H-Index: 66
view all 8 authors...
2 CitationsSource
#1Stefania ZamboniH-Index: 9
Last. Claudio SimeoneH-Index: 28
view all 10 authors...
Source
#1Eduard Roussel (Katholieke Universiteit Leuven)H-Index: 3
#2Riccardo Campi (UniFI: University of Florence)H-Index: 13
Last. Maarten Albersen (Katholieke Universiteit Leuven)H-Index: 26
view all 33 authors...
Abstract Background Cytoreductive nephrectomy (CN) plays an important role in the treatment of a subgroup of metastatic renal cell carcinoma (mRCC) patients. Objective We aimed to evaluate morbidity associated with this procedure and identify potential predictors thereof to aid patient selection for this procedure and potentially improve patient outcomes. Design, setting, and participants Data from 736 mRCC patients undergoing CN at 14 institutions were retrospectively recorded in the Registry f...
2 CitationsSource
#1Marta Laganà (University of Brescia)H-Index: 5
#2Salvatore Grisanti (University of Brescia)H-Index: 21
Last. Alfredo Berruti (University of Brescia)H-Index: 66
view all 14 authors...
Etoposide, doxorubicin and cisplatin plus oral mitotane (EDP-M) comprise the reference regimen in the management of patients with adrenocortical carcinoma (ACC). In this paper, we described the outcome of 58 patients with advanced/metastatic ACC consecutively treated with EDP-M in a reference center for this rare disease in Italy. In this series, EDP-M obtained a partial response in 50% of patients; median progression free survival (PFS) and overall survival were 10.1 months (95% Confidence Inte...
7 CitationsSource
#1Angela PecoraroH-Index: 2
#1Angela PecoraroH-Index: 8
Last. Pierre I. KarakiewiczH-Index: 116
view all 13 authors...
INTRODUCTION AND OBJECTIVE:Five-year other cause mortality (OCM) after nephrectomy for non-metastatic renal cell carcinoma (nmRCC) should be marginal in properly selected surgical candidates. We ex...
Source
Source